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ikojima@gunma-u.ac.jpAbstractGlucose activates the glucose-sensing receptor T1R3 and facilitates its own metabolism in
pancreatic b-cells. An inhibitor of this receptor would be helpful in elucidating the
physiological function of the glucose-sensing receptor. The present study was conducted to
examine whether or not lactisole can be used as an inhibitor of the glucose-sensing receptor.
In MIN6 cells, in a dose-dependent manner, lactisole inhibited insulin secretion induced by
sweeteners, acesulfame-K, sucralose and glycyrrhizin. The IC50 wasw4 mmol/l. Lactisole
attenuated the elevation of cytoplasmic Ca2C concentration ([Ca2C]c) evoked by sucralose
and acesulfame-K but did not affect the elevation of intracellular cAMP concentration
([cAMP]c) induced by these sweeteners. Lactisole also inhibited the action of glucose in MIN6
cells. Thus, lactisole significantly reduced elevations of intracellular [NADH] and intracellular
[ATP] induced by glucose, and also inhibited glucose-induced insulin secretion. To further
examine the effect of lactisole on T1R3, we prepared HEK293 cells stably expressing mouse
T1R3. In these cells, sucralose elevated both [Ca2C]c and [cAMP]c. Lactisole attenuated the
sucralose-induced increase in [Ca2C]c but did not affect the elevation of [cAMP]c. Finally,
lactisole inhibited insulin secretion induced by a high concentration of glucose in mouse
islets. These results indicate that the mouse glucose-sensing receptor was inhibited by
lactisole. Lactisole may be useful in assessing the role of the glucose-sensing receptor in
mouse pancreatic b-cells.Key Words
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.0 UJournal of Endocrinology
(2015) 226, 57–66IntroductionGlucose is a primary stimulator of insulin secretion in
pancreatic b-cells and modulates the effects of incretins
and acetylcholine (Ashcroft & Rorsman 1989, Rasmussen
et al. 1990, Rorsman 1997, Newsholme et al. 2014). We
have shown recently that T1R3, a subunit of the sweet
taste receptor (Nelson et al. 2001, Temussi 2007), functions
as a glucose-sensing receptor in b-cells (Malaisse 2014,Nakagawa et al. 2014, Kojima et al. 2015). This receptor
is activated by glucose, and promotes metabolism of
fuels in b-cells leading to an increase in ATP (Nakagawa
et al. 2014). Since knockdown of T1R3 attenuates
glucose-induced elevation of intracellular ATP ([ATP]c),
the glucose-sensing receptor T1R3 is involved in the
action of glucose (Kojima et al. 2015). At present, thesed under a Creative Commons
nported License.
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Research K HAMANO and others Inhibition of T1R3 by lactisole 226 :1 58physiological role of this receptor in b-cells is not
completely elucidated. A specific and useful inhibitor of
T1R3 would be helpful in assessing the physiological
functions of the glucose-sensing receptor in b-cells.
T1R3 belongs to the class C G protein-coupled
receptor and forms a heterodimer with T1R2 or T1R1.
The T1R2/T1R3 heterodimer functions as the sweet taste
receptor while T1R3/T1R1 functions as the umami
receptor (Nelson et al. 2001, Roper 2007, 2013, Temussi
2007). T1R3 is a key molecule in sweet taste perception
and many activators and inhibitors were identified
(Temussi 2007). Among these inhibitors, lactisole,
which is 2-(4-methoxyphenol) propionic acid, inhibits
perception of sweet taste by acting on T1R3 (Johnson
et al. 1994, Sclafani & Perez 1997, Xu et al. 2004). Jiang
et al. (2005) showed that lactisole acts on the trans-
membrane domain (TMD) of T1R3. They further nar-
rowed down the specific region in TMD that interacts
with lactisole and identified critical residues in the TMD
of T1R3 (Jiang et al. 2005).
Subunits of the sweet taste receptor are also expressed
in extragustatory organs including enteroendocrine cells
(Bezencon et al. 2007, Margolskee et al. 2007, Jang et al.
2010), pancreatic b-cells (Nakagawa et al. 2009, Geraedts
et al. 2012, Kyriazis et al. 2012) and adipocytes (Masubuchi
et al. 2013). Unlike taste cells of the tongue, the expression
level of T1R2 is much lower compared to that of T1R3 in
these cells (Masubuchi et al. 2013, Nakagawa et al. 2013,
Medina et al. 2014, Ohtsu et al. 2014), and a homodimer of
T1R3 may function as the sweet taste-sensing receptor
(Masubuchi et al. 2013, Nakagawa et al. 2013, Medina et al.
2014, Ohtsu et al. 2014). Specifically in b-cells, the
expression of T1R2 is far less than that of T1R3 (Medina
et al. 2014). Furthermore, knockdown of T1R3 attenuated
the effects of sweeteners whereas knockdown of T1R2 was
ineffective (Nakagawa et al. 2013). It is quite likely that
a major component of the sweet taste-sensing receptor in
b-cells may be a homodimer of T1R3 (Nakagawa et al.
2013, Kojima et al. 2015). The physiological function and
its role in the regulation of insulin secretion are largely
unknown. In this regard, the inhibitor of the glucose-
sensing receptor, if any, is useful to assess the role of the
receptor in the regulation of insulin secretion.
To block the glucose-sensing receptor in b-cells, the
putative compound should inhibit the homodimer of
T1R3. Among various inhibitors of sweet taste perception,
lactisole is the most interesting candidate since it acts
on the specific region of T1R3 (Xu et al. 2004, Jiang et al.
2005). Unfortunately, it was reported that the effect of
lactisole was dependent on species. Thus, it inhibits sweethttp://joe.endocrinology-journals.org
DOI: 10.1530/JOE-15-0102
 2015 The authors
Printed in Great Britaintaste sensation in humans (Johnson et al. 1994) whereas it
is ineffective in rodents (Johnson et al. 1994, Jiang et al.
2005). These reports negate the function of lactisole as
an inhibitor of the glucose-sensing receptor in rodents.
In this regard, Oya et al. (2011) reported recently that
lactisole inhibits the umami receptor function in MIN6
cells. Their results suggest that mouse T1R3 (mT1R3) is not
totally insensitive to lactisole. Nevertheless, since their
results are apparently contradictory to previous reports
(Johnson et al. 1994, Jiang et al. 2005), investigators in the
field of taste research cast some doubts on their results.
This is an important issue since, if it is true, lactisole can be
used as an inhibitor of the glucose-sensing receptor
in humans and rodents. Given that properties of the
glucose-sensing receptor in b-cells may be slightly
different from those of the canonical sweet taste receptor
in the taste buds, it is indeed worth testing whether the
glucose-sensing receptor expressed in mouse b-cells is
inhibited by lactisole. In the present study, we examined
this possibility. The results clearly show that lactisole
inhibits the mouse glucose-sensing receptor mT1R3.
Lactisole may provide a useful pharmacological tool to
assess the function of the glucose-sensing receptor in
pancreatic b-cells.Materials and methods
Materials
Lactisole and sucralose were obtained from Sigma–
Aldrich. Acesulfame-K and glycyrrhizin were from Wako
Pure Chemical Industry (Osaka, Japan). These chemicals
were dissolved in Hank’s balanced salt solution (HBSS)
containing 138 mmol/l NaCl, 5.4 mmol/l KCl, 1.3 mmol/l
CaCl2, 0.44 mmol/l KH2PO4, 0.5 mmol/l MgCl2,
0.38 mmol/l MgSO4, 0.34 mmol/l Na2HPO4, 5.5 mmol/l
D-glucose and 10 mmol/l HEPES/NaOH (pH 7.4). To
prepare lactisole-containing buffer, we dissolved the
compound in HBSS or Krebs–Ringer–HEPES (KRH) buffer
and pH was adjusted to 7.4 by adding NaOH.Cell culture
MIN6 cells (Miyazaki et al. 1990) were grown in DMEM
containing a high concentration of glucose (Invitrogen)
and 10% fetal bovine serum (FBS) (Sigma–Aldrich) and
cultured in a humidified incubator with 95% air and 5%
CO2 at 37 8C. HEK293 cells were cultured in DMEM
containing 10% FBS.Published by Bioscientifica Ltd
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Research K HAMANO and others Inhibition of T1R3 by lactisole 226 :1 59Measurement of insulin secretion
MIN6 cells were cultured in a 24-well plate and incubated
for 48 h. Cells were then incubated for 1 h in KRH buffer
containing 136 mmol/l NaCl, 4.8 mmol/l KCl, 1.3 mmol/l
CaCl2, 1.2 mmol/l MgSO4, 1.2 mmol/l KH2PO4,
5.0 mmol/l NaHCO3, 10 mmol/l HEPES/NaOH (pH 7.4)
and 0.1% BSA. Cells were then incubated for 1 h in the
same buffer containing 5.5 mmol/l glucose in the presence
and absence of various agents. The supernatant was
collected and centrifuged at 300 g for 10 min to remove
cell debris. The insulin concentration in the supernatant
was measured by RIA (Eiken Chemical, Tokyo, Japan)
according to the manufacturer’s protocol (Nakagawa et al.
2009). Insulin content was measured as described pre-
viously (Nakagawa et al. 2009) and secreted insulin was
expressed as a percent of the insulin content. Statistical
analysis was performed by using Student’s t-test.
C57BL/6J (B6) and T1R3-null mice were obtained from
the Jackson Laboratory (Bar Harbor, ME, USA). Mouse
pancreatic islets were isolated by using collagenase (Gotoh
et al. 1985). Isolated islets were preincubated for 1 h in
KRH buffer. Then the islets were incubated for 1 h in KRH
buffer containing 5.5 mmol/l glucose and various com-
pounds unless otherwise mentioned. The supernatant was
collected and insulin concentration was measured by RIA
(Nakagawa et al. 2009). Secreted insulin was expressed as
a percent of the insulin content.Measurement of cytoplasmic Ca2C concentration and
NADH in MIN6 cells
HBSS was used for measurement of cytoplasmic Ca2C
concentration ([Ca2C]c) and intracellular NADH concen-
tration [NADH].
[Ca2C]c was monitored by using a fluorescent Ca
2C
indicator fluo-8. MIN6 cells were loaded with fluo-8 by
incubating in HBSS containing 4 mmol/l fluo-8/AM for
20 min at room temperature. Cells were placed on a
35 mm glass bottom culture dish. Before the measure-
ment, cells were incubated in HBSS and were visualized
with a 40 UApo/340 objective lens (Olympus). To detect
the fluorescence images, we used the AQUACOSMOS/
ASHURA imaging system (Hamamatsu Photonics, Hama-
matsu, Japan; Nakagawa et al. 2009). The values (F) were
normalized to each initial value (F0) and the relative
fluorescence change was referred to as F/F0 (Nakagawa
et al. 2009). [NADH] was monitored by measuring auto-
fluorescence using a 380 nm emission filter. In each exp-
eriment, recordings were obtained in more than ten cells.http://joe.endocrinology-journals.org
DOI: 10.1530/JOE-15-0102
 2015 The authors
Printed in Great BritainResults are expressed as meanGS.E.M. of accumulated data
obtained in multiple experiments. For determination of
dose–response relationship and analyses of the effects of
inhibitors, the area under the curve (AUC) was calculated.
Statistical analysis was performed using Student’s t-test.Measurement of cytoplasmic cAMP concentration in
MIN6 cells
Changes in cytoplasmic cAMP concentration ([cAMP]c)
were monitored by using Epac1-camps (Nikolaev et al.
2004) kindly provided by Dr Martin Lohse (University of
Wu¨rzburg, Germany). MIN6 cells were transiently trans-
fected with 5.4 mg of plasmid encoding Epac1-camps using
Lipofectamine 2000 transfection reagent (Invitrogen;
Nakagawa et al. 2009). Transfected cells were incubated
in HBSS. For imaging, cells were visualized with a 40
UApo/340 objective lens (Olympus). The Epac1-camps
excitation wavelength was 440 nm and attenuated by 6%
using neutral density filters. For dual emission ratio
imaging for enhanced cyan fluorescent protein and
enhanced yellow fluorescent protein, we used AQUA-
COSMOS/ASHURA, a 3CCD based fluorescence energy
transfer imaging system (Hamamatsu Photonics).Measurement of cytoplasmic ATP in MIN6 cells
MIN6 cells expressing luciferase (Nakagawa et al. 2014)
were seeded into a culture plate-96 and incubated for 2–3
days before the measurement of ATP. Cells were then
incubated for 20 min in HBSS containing 50 mmol/l
D-luciferin potassium salt (Wako Pure Chemical Industry)
in a 37 8C incubator. To measure the basal ATP concen-
tration (Lo), we counted the emitted photons with an
EnSpire (Perkin Elmer, Waltham, MA, USA) for 20 min.
The cells were then incubated in the presence or absence
of stimulatory agents. We counted the emitted photon for
1 h. These values (L) were normalized to each basal value
(Lo) so that the relative luminescence changes were
referred to as L/Lo (Nakagawa et al. 2014).Establishment of HEK293 cell lines expressing mT1R3
HEK293 cells cultured in a 100 mm culture dish were
dispersed with PBS containing 0.05% trypsin–EDTA (Life
Technologies). After washing with growth medium, cells
were resuspended in Electroporation Buffer (Bio-Rad). Then
0.55 ml of cell aliquot was mixed with 0.2 ml of mT1R3
pcDNA3.1Cneo (a gift from Yutaka Maruyama, Ajinomoto
Co., Inc., Kawasaki, Japan; 30 mg) in a 0.4 cm-gap cuvettePublished by Bioscientifica Ltd
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Research K HAMANO and others Inhibition of T1R3 by lactisole 226 :1 60before a single pulse of electroporation was administered
using Gene Pulser Xcell (Bio-Rad) set at voltage 200 V and
time constant 28 ms. Cells were selected for antibiotic
resistance to G-418 sulfate (1 g/l, Wako Pure Chemical
Industry) for 10 days. One hundred and twenty resistant
colonies were expanded, and their Ca2C responses to the
sweet taste receptor agonist were evaluated by using
fluorescence microscopy. Six responding colonies were
isolated, and the strongest responding cell line was used for
all analyses.Results
We first examined the effect of various concentrations of
lactisole on insulin secretion induced by T1R3 agonists
in MIN6 cells. In these cells, an artificial sweetener
sucralose, which activates the glucose-sensing receptor
T1R3 (Nakagawa et al. 2009, 2013, 2014), induced an
approximately threefold increase in insulin secretion in
the presence of 5.5 mmol/l glucose. This increase in
insulin secretion induced by sucralose was inhibited
by an addition of lactisole (Fig. 1A). In the presence of
3 mmol/l lactisole, sucralose-induced secretion was
w60%. At 10 mmol/l, lactisole nearly completely blocked
the effect of sucralose. The IC50 of the effect of lactisole was
w4.0 mmol/l. Similarly, acesulfame-K induced a fourfold
increase in insulin secretion and lactisole inhibited
acesulfame-K-induced insulin secretion in a dose-depen-
dent manner (Fig. 1B). In addition, insulin secretion
induced by glycyrrhizin was inhibited by lactisole
(Fig. 1C). In sharp contrast, lactisole did not affect insulin
secretion induced by a depolarizing concentration of KCl
(Fig. 1D). Lactisole did not affect the viability of the cells as
assessed by using Trypan blue (data not shown). Kyriazis
et al. (2014) recently reported that lactisole increased basal
insulin secretin in human b-cells. We examined the effectA
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Figure 1
Effect of lactisole on insulin secretion in MIN6 cells. MIN6 cells were
incubated with 40 mmol/l sucralose (A), 40 mmol/l acesulfame-K (B),
3 mmol/l glycyrrhizin (C) and 40 mmol/l KCl (D) in the presence and absence
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Printed in Great Britainof lactisole on basal secretin in MIN6 cells. As shown in
Fig. 1E, lactisole did not affect the basal secretion.
We then examined the effect of lactisole on sucralose-
induced elevation of [Ca2C]c. As shown in Fig. 2A,
sucralose induced an immediate increase in [Ca2C]c,
which was followed by sustained elevation of [Ca2C]c.
The effect of sucralose was markedly inhibited by 5 mmol/l
lactisole. Figure 2B depicts the effect of lactisole on
sucralose-induced elevation of [Ca2C]c assessed by measur-
ing AUC. Likewise, elevation of [Ca2C]c induced
by acesulfame-K was significantly inhibited by lactisole
(Fig. 2C and D). In contrast, lactisole did not affect
elevation of [Ca2C]c induced by a high concentration of
potassium (Fig. 2E and F). In addition to [Ca2C]c, sucralose
also induced elevation of [cAMP]c (Fig. 3A). In sharp
contrast to the effects on [Ca2C]c, lactisole did not affect
sucralose-induced elevation of [cAMP]c (Fig. 3A and B).
Similarly, lactisole did not affect the elevation of [cAMP]c
induced by acesulfame-K (Fig. 3C and D).
The preceding results suggest that lactisole inhibits
[Ca2C]c response mediated by mT1R3. To further confirm
this, we permanently expressed mT1R3 in HEK293 cells
and examined the effect of lactisole. In naı¨ve HEK293 cells
or mock-transfected HEK293 cells, sucralose did not cause
any change in [Ca2C]c (data not shown). In HEK293 cells
expressing mT1R3, sucralose induced a transient elevation
of [Ca2C]c (Fig. 4A). It is of note that [Ca
2C]c response to
sucralose was obtained by transfection of mT1R3 alone
and transfection of gustducin or a chimeric G protein
(Nelson et al. 2001) was not required. Elevation of [Ca2C]c
induced by sucralose was markedly inhibited by lactisole
(Fig. 4B). In contrast, lactisole did not affect elevation of
[cAMP]c induced by sucralose (Fig. 4B and C). Likewise,
acesulfame-K induced biphasic increase in [Ca2C]c, which
was inhibited by lactisole (Fig. 4E and F).
We reported previously that activation of the glucose-
sensing receptor led to an increase in [ATP]c by facilitatingGlycyrrhizin KCI Basal
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of various concentrations of lactisole, and insulin in the medium was
measured. Effects of lactisole in the absence of stimulator were also
examined (E). Values are the meanGS.E.M. for four experiments.
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Figure 2
Effect of lactisole on elevation of [Ca2C]c induced by sucralose and
acesulfame-K in MIN6 cells. (A) MIN6 cells were stimulated by 40 mmol/l
sucralose in the presence (filled circle) and absence (open circle) of 5 mmol/l
lactisole and changes in [Ca2C]c were monitored. Values are the mean of
ten determinations. Note that 40 mmol/l mannitol did not affect [Ca2C]c.
(B) Cells were stimulated as shown in A and quantitative analysis was done
by measuring AUC. Values are the meanGS.E.M. for three experiments.
*P!0.01 vs without lactisole. (C) MIN6 cells were stimulatedwith 30 mmol/l
acesulfame-K in the presence (filled circle) and absence (open circle) of
5 mmol/l lactisole and changes in [Ca2C]c were monitored. Values are the
mean of ten determinations. (D) Cells were stimulated as shown in C and
AUC was calculated. Values are the meanGS.E.M. for three experiments.
*P!0.01 vs without lactisole. (E) MIN6 cells were stimulated by 40 mmol/l
KCl in the presence (filled circle) and absence (open circle) of 5 mmol/l
lactisole. Values are the mean of responses of 20 determinations.
(F) Experiments were performed as shown in E and AUC was calculated.
Values are the meanGS.E.M. for 20 determinations.
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Figure 3
Effect of lactisole on elevation of [cAMP]c in MIN6 cells. (A) Epac1-camps-
expressing MIN6 cells were stimulated by 40 mmol/l sucralose in the
presence (filled circle) and absence (open circle) of 5 mmol/l lactisole.
Changes in [cAMP]c was monitored. Values are the mean of ten
determinations. (B) Experiments were performed as mentioned in A and
AUC was calculated. Values are the meanGS.E.M. for ten determinations
and representative of two experiments. (C) Cells were stimulated by
40 mmol/l acesulfame-K in the presence (filled circle) and absence (open
circle) of 5 mmol/l lactisole. Values are the mean of ten determinations.
(D) Experiments were performed as in C and AUCwas calculated. Values are
the meanGS.E.M. of ten determinations and the representative of two
experiments.
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Research K HAMANO and others Inhibition of T1R3 by lactisole 226 :1 61glucose metabolism (Nakagawa et al. 2014). Accordingly,
artificial sweeteners increase [ATP]c even though they do
not serve as substrates for glycolysis. We next examined
the effect of lactisole on elevation of [NADH] and [ATP]c
induced by a sweetener sucralose. As shown in Fig. 5A,
sucralose increased [NADH] in MIN6 cells. Lactisole inhi-
bited the effect of sucralose on [NADH] (Fig. 5A and B).http://joe.endocrinology-journals.org
DOI: 10.1530/JOE-15-0102
 2015 The authors
Printed in Great BritainLikewise, addition of sucralose induced an immediate
increase in [ATP]c, which was markedly inhibited by
lactisole (Fig. 5C and D).
We next examined whether lactisole modulates the
effect of glucose in MIN6 cells. As shown in Fig. 6A,
25 mmol/l glucose induced an increase in [NADH].
Glucose-induced elevation of [NADH] was significantly
reduced by lactisole (Fig. 6A and B). High concentration of
glucose also evoked a biphasic increase in [ATP]c (Fig. 6C).
Lactisole markedly reduced the elevation of [ATP]c induced
by glucose (Fig. 6C and D). It is well known that glucose
elevates [ATP]c and thereby inhibits the ATP-sensitive
potassium (KATP) channel (Ashcroft & Rorsman 1989,
Rorsman 1997). Resultant depolarization of the plasma
membrane induces Ca2C entry via the voltage-dependent
Ca2C channel (Ashcroft & Rorsman 1989, Rorsman 1997).
As shown in Fig. 6E, 25 mmol/l glucose induced elevation
of [Ca2C]c after a certain lag period. The glucose-induced
elevation of [Ca2C]c was delayed and significantly blunted
by the addition of lactisole (Fig. 6E and F). In agreementPublished by Bioscientifica Ltd
[C
a2
+ ] c
[C
a2
+ ] c
2
A B
C D
E F
1
0 5
AU
C
5
0
0 5
*
Time (min)
Sucralose
Sucralose
Acesulfame-K
[cA
MP
] c 0.6
0.5
2
1
0 5
Time (min)
0 5
*
Time (min)
Lactisole
(mmol/l)
AU
C
0.2
0.1
0 5Lactisole
(mmol/l)
AU
C
20
40
0 5Lactisole
(mmol/l)
Figure 4
Effect of lactisole on [Ca2C]c and [cAMP]c in HEK293 cells stably expressing
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Effect of lactisole on changes in [NADH] and [ATP]c in MIN6 cells. (A) MIN6
cells were stimulated by 10 mmol/l sucralose in the presence (filled circle)
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the glucose concentration in mediumwas 5.5 mmol/l. (B) Experiments were
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monitored. Values are the mean of four experiments. (D) Experiments
were performed as shown in C and AUC was calculated. Values are the
meanGS.E.M. for four experiments. *P!0.05 vs without lactisole.
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Research K HAMANO and others Inhibition of T1R3 by lactisole 226 :1 62with this observation, lactisole significantly reduced
insulin secretion induced by glucose (Fig. 7A). It is
known that glucose action in b-cells is exerted through
two different pathways: a triggering pathway or KATP
channel-dependent pathway, and an amplifying pathway
or KATP channel-independent pathway (Gembal et al. 1992,
Sato et al. 1992, Henquin 2009). It was reported that the
KATP channel independent pathway was inhibited by an
inhibitor of glucose recognition site in the plasma
membrane (Aizawa et al. 1994). To confirm this, we
examined whether or not lactisole inhibits insulin
secretion induced by glucose in the presence of diazoxide
and depolarizing concentration of KCl. As shown in
Fig. 7B, lactisole significantly reduced insulin secretion inhttp://joe.endocrinology-journals.org
DOI: 10.1530/JOE-15-0102
 2015 The authors
Printed in Great Britainthe presence of glucose, diazoxide and high concentration
of KCl.
Finally, we examined the effect of lactisole in mouse
pancreatic islets. Lactisole did not alter the basal secretion
of insulin (Fig. 8A). Glucose induced an approximately
fivefold increase in insulin secretion in mouse islets.
Lactisole attenuated insulin secretion induced by glucose
(Fig. 8A). In contrast, lactisole did not affect insulin
secretion induced by a depolarizing concentration of
potassium (Fig. 8B). We also examined the effect of
lactisole in islets obtained from T1R3 knockout mice. As
shown in Fig. 8C, insulin secretion induced by glucose was
reduced in T1R3-null islets. In these islets, lactisole did not
affect glucose-induced insulin secretion.Discussion
Results obtained in the present study demonstrated that
lactisole inhibited insulin secretion induced by sweetenersPublished by Bioscientifica Ltd
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Effect of lactisole on insulin secretion in MIN6 cells. (A) MIN6 cells were
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*P!0.01 vs without lactisole.
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w4 mmol/l. In contrast, lactisole had no effect on insulin
secretion induced by the depolarizing concentration of
KCl. Likewise, lactisole inhibited [Ca2C]c response to
sweeteners without affecting the [Ca2C]c response to
KCl. Furthermore, lactisole blocked the increase in
[ATP]c induced by the sweetener. These results clearly
show that the glucose-sensing receptor in mouse b-cells
is inhibited by lactisole. Further support came from the
experiments performed in HEK293 cells. In HEK293 cells
stably expressing mT1R3, sucralose evoked an elevation of
[Ca2C]c, which was inhibited by lactisole. It should behttp://joe.endocrinology-journals.org
DOI: 10.1530/JOE-15-0102
 2015 The authors
Printed in Great Britainnoted that doses of lactisole that inhibited mT1R3 were
slightly higher than that which inhibited human T1R3
(hT1R3; Johnson et al. 1994, Xu et al. 2004, Jiang et al.
2005). Thus, hT1R3 was blocked by 1 mmol/l lactisole
(Jiang et al. 2005) whereas 1 mmol/l lactisole showed only
a small inhibitory effect on mT1R3 (Fig. 1). mT1R3 was less
sensitive to lactisole as compared to hT1R3. In any event,
lactisole was able to inhibit mT1R3, although slightly
higher concentrations were needed. This notion is
apparently different from what has been widely thought
(Johnson et al. 1994, Sclafani & Perez 1997, Xu et al. 2004).
In this regard, Jiang et al. (2005) used a fixed dose of
lactisole, i.e. 1 mmol/l, and showed that mT1R3 was
resistant to lactisole. In fact, they prepared series of
chimeric receptors replacing hT1R3 sequences with the
mouse ones, and identified a region responsible for
inhibition by lactisole. However, even their insensitive
chimeras were inhibited when higher concentrations of
lactisole were administered (Jiang et al. 2005). TakenPublished by Bioscientifica Ltd
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Research K HAMANO and others Inhibition of T1R3 by lactisole 226 :1 64together, mT1R3 is not totally insensitive to lactisole, but
when compared to hT1R3, it is less sensitive to lactisole. If
one applies a slightly higher concentration of lactisole, for
example 5 mmol/l, it significantly inhibits mT1R3 signal-
ing. As shown in Fig. 8C, lactisole did not affect insulin
secretion in islets obtained from T1R3-null mice. This
result suggests that lactisole does not have non-specific
toxic effect in this condition.
Previously, we showed that gurmarin, an inhibitor of
the sweet taste receptor (Shigemura et al. 2008), attenuated
elevation of [Ca2C]c induced by sucralose in MIN6 cells
(Nakagawa et al. 2009). The results indicate that gurmarin
acts as an inhibitor of the glucose-sensing receptor
expressed in pancreatic b-cells. It should be noted that
gurmarin does not inhibit all of the actions of sweet taste
receptor agonists in b-cells. For example, gurmarin
inhibits the effect of sucralose but effects of acesulfame-K
and glycyrrhizin are totally insensitive to gurmarin
(Nakagawa et al. 2013). Since sucralose and acesulfame-K
bind to a similar portion of the Venus flytrap of the sweet
taste receptor (Masuda et al. 2012), the mechanism
underlying the preferential effects of gurmarin (Nakagawa
et al. 2013) is not clear at present. Another unique aspect ofhttp://joe.endocrinology-journals.org
DOI: 10.1530/JOE-15-0102
 2015 The authors
Printed in Great Britaingurmarin is that it only inhibits [Ca2C]c response induced
by sucralose and elevation of [cAMP]c is not affected
(Nakagawa et al. 2013). In this regard, gurmarin acts as a
biased antagonist for T1R3 in many respects and attenu-
ates a limited signaling cascade evoked by a limited
number of agonists. As reported previously (Nakagawa
et al. 2013), the glucose-sensing receptor is quite unique in
the sense that various types of agonists generate distinct
patterns of intracellular signals. Many sweet compounds
act as biased agonists and induce diverse patterns of
intracellular responses (Nakagawa et al. 2013, Kojima et al.
2014, Ohtsu et al. 2014).
In contrast to gurmarin, lactisole inhibited the effects
of sucralose, acesulfame-K, glycyrrhizin and glucose on
insulin secretion, indicating that lactisole is able to block
the effect of acesulfame-K, glycyrrhizin and glucose as well.
With regard to intracellular messengers, lactisole inhibited
the [Ca2C]c response to acesulfame-K and sucralose but
not the [cAMP]c responses to the sweeteners. Again, the
inhibitory actions of lactisole are biased in some sense. Our
previous study (Nakagawa et al. 2013) showed that
sucralose increased [cAMP]c by a Gs-dependent mechanism
whereas acesulfame-K-induced elevation of cAMP was also
dependent on Ca2C. Presumably, lactisole is ineffective to
inhibit the Gs-dependent pathway.
Kyriazis et al. (2014) recently postulated that the sweet
taste receptor expressed in b-cells inhibits basal secretion
of insulin. Their proposal is based on the observation
obtained in human islets using lactisole. They showed that
lactisole increased insulin secretion in the presence of 3.0
or 5.5 mmol/l glucose in human islets. In that study, they
also assessed basal insulin secretion in T1R2 knockout
islets. They showed that insulin secretion in the presence of
3.0 or 5.5 mmol/l glucose was not altered in T1R2-null islets
(Kyriazis et al. 2012, 2014). These results are apparently
inconsistent with their proposal. Because our present
results also show that lactisole did not affect basal secretion
in mouse b-cells, results obtained in human islets using
lactisole may have provided inconsistency. At present, the
reason why they observed stimulation of insulin secretion
by lactisole is not clear. As mentioned in the ‘Materials and
methods’ section, lactisole solution is acidic. If they did not
adjust pH of the KRH buffer containing lactisole, pH of the
buffer may have been lower than should be. Because b-cells
express the proton receptor (Nakakura et al. 2012), low pH
might have stimulated insulin secretion independent of
the action of lactisole. Further studies are necessary to
address these points.
In the present study, we stably transfected mT1R3 in
HEK293 cells and observed that mT1R3 responded toPublished by Bioscientifica Ltd
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Research K HAMANO and others Inhibition of T1R3 by lactisole 226 :1 65sucralose. The results clearly indicate that mT1R3 alone
functions as the sweet taste-sensing receptor. Presumably,
a homodimer of mT1R3 functions as a signaling receptor.
It should be mentioned that we did not transfect
gustducin or a chimeric G protein simultaneously. This
suggests that a homodimer of mT1R3 may couple to
endogenous G proteins expressed in HEK cells, presum-
ably G proteins of the Gq family. The present results differ
from those that previously reported that a chimeric G
protein was required to observe the effect of ectopically
expressed T1Rs (Nelson et al. 2001). An exact reason for
this discrepancy is not clear at present. The efficiency of
transfection or sensitivity of the detection of changes in
[Ca2C]c may be possible reasons.
We showed recently that sucralose increased [ATP]c
in MIN6 cells (Nakagawa et al. 2014). The effect of
sucralose is observed even in the absence of ambient
glucose. Sucralose is an artificial sweetener and is not
metabolized in b-cells. We interpret these results that
sucralose, by activating the glucose-sensing receptor T1R3,
facilitates metabolism in b-cells and increased [ATP]c.
Since sucralose is capable of elevating [ATP]c in the
absence of glucose, sucralose perhaps mobilizes sub-
strate(s) from a source(s) outside the glycolytic pathway
and generates ATP (Kojima et al. 2015). In addition,
sucralose enhances the elevation of [ATP]c induced by
methylsuccinate. This suggests that metabolism in mito-
chondria may also be activated by the glucose-sensing
receptor T1R3 (Kojima et al. 2015).
The present results show that lactisole inhibited the
action of glucose on the glucose-sensing receptor. Thus,
lactisole attenuated glucose-induced increases in [NADH]
and [ATP]c. These results are consistent with the notion that
lactisole inhibits the glucose-sensing receptor and thereby
attenuated the facilitation of the glucose metabolism
(Medina et al. 2014, Nakagawa et al. 2014). More impor-
tantly, lactisole inhibited insulin secretion induced by
glucose. As shown in Fig. 6C, lactisole attenuated the
elevation of [ATP]c induced by glucose. In addition, lactisole
also reduced elevation of [Ca2C]c induced by glucose. Given
that glucose increases [Ca2C]c by inhibiting the KATP
channel and causing Ca2C entry via the voltage-dependent
Ca2C channel, the KATP channel dependent pathway is
inhibited partially by lactisole. As shown in Fig. 7B, lactisole
inhibited insulin secretion induced by glucose in the
presence of diazoxide and high concentration of KCl.
Hence, the KATP channel independent pathway or the
amplifying pathway is also inhibited partially by lactisole.
These results are consistent with the report by Aizawa et al.
(1994). Collectively, the glucose-sensing receptor ishttp://joe.endocrinology-journals.org
DOI: 10.1530/JOE-15-0102
 2015 The authors
Printed in Great Britaininvolved in both KATP channel-dependent and independent
pathways. This is not surprising because the glucose-sensing
receptor modulates glucose metabolism and promotes ATP
generation (Kojima et al. 2015).
Lactisole is commercially available and may be useful
to assess the function and physiological role of the
glucose-sensing receptor T1R3 expressed in b-cells.
Again, we should keep in mind that lactisole inhibits the
calcium signaling system activated by the glucose-sensing
receptor, but activation of the cAMP pathway is not
affected by the compound. We may underestimate the role
of the glucose-sensing receptor. In any event, further
studies are necessary to elucidate the role of the glucose-
sensing receptor in the action of glucose in b-cells.Declaration of interest
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